Patient Guide: A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 331 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05578976
Status: ACTIVE_NOT_RECRUITING
Condition: Diffuse Large B-Cell Lymphoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 331 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Yuma, Arizona
  • Little Rock, Arkansas
  • • And 328 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily